FDA approves venetoclax for CLL or SLL, with or without 17 p deletion, after one prior therapy

[Lo-la]

fda.gov/Drugs/InformationOn...

Hello All,

I wanted to share this link with you, I apologize if it’s already been posted.

Best wishes,

Lo-la

[Cllcanada Top Poster CURE Hero]

Certainly good news for patients in the U.S. The protocol is actually venetoclax and rituxan.

~chris

[bhayes84]

Non trivial side effects fairly often:

"Grade 3 or 4 neutropenia developed in 64% of these patients, and grade 4 neutropenia developed in 31%. Serious adverse reactions occurred in 46% of patients. Serious infections developed in 21% of patients, most commonly pneumonia (9%)."

Important question is when insurance and assistance groups will cover the cost.